{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:42:58Z","timestamp":1792082578775,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pt.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T09:35:54Z","timestamp":1602495354000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["Triple Artemisinin-Based Combination Therapies for Malaria \u2013 A New Paradigm?"],"prefix":"10.1016","volume":"37","author":[{"given":"Rob W.","family":"van der Pluijm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanaki","family":"Amaratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dhorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen M.","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2020.09.011_bb0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.pt.2020.09.011_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050226","article-title":"Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity","volume":"5","author":"Okell","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0020","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(84)92057-9","article-title":"Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria","volume":"2","author":"Li","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.09.011_bb0025","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/0035-9203(94)90460-X","article-title":"Clinical trials of artemisinin and its derivatives in the treatment of malaria in China","volume":"88","author":"Li","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.09.011_bb0030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0035","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0040","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/infdis\/170.4.971","article-title":"Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination","volume":"170","author":"Nosten","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0045","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1128\/AAC.00287-13","article-title":"Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization","volume":"57","author":"White","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1475-2875-10-278","article-title":"The parasite clearance curve","volume":"10","author":"White","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0055","series-title":"Guidelines for the Treatment of Malaria","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.pt.2020.09.011_bb0060","series-title":"Status Report on Artemisinin Resistance and ACT Efficacy","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.pt.2020.09.011_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(03)15162-8","article-title":"Artesunate combinations for treatment of malaria: meta-analysis","volume":"363","author":"Adjuik","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.09.011_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.09.011_bb0075","series-title":"World Malaria Report","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.pt.2020.09.011_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"Flegg","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0085","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0090","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.09.011_bb0095","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.pt.2020.09.011_bb0105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12936-018-2625-6","article-title":"Heterogeneous distribution of k13 mutations in Plasmodium falciparum in Laos","volume":"17","author":"Iwagami","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pt.2017.01.004","article-title":"How to contain artemisinin- and multidrug-resistant falciparum malaria","volume":"33","author":"Dondorp","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.09.011_bb0115","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003\u20132013): the role of parasite genetic factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3201\/eid2304.161872","article-title":"Treatment failure of dihydroartemisinin\/piperaquine for Plasmodium falciparum malaria, Vietnam","volume":"23","author":"Phuc","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0130","article-title":"Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia","author":"Mairet-Khedim","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0135","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","article-title":"Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.pt.2020.09.011_bb0140","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-3156.2006.01690.x","article-title":"Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.pt.2020.09.011_bb0145","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/AAC.00039-16","article-title":"Efficacy and safety of pyronaridine-artesunate for treatment of uncomplicated Plasmodium falciparum malaria in Western Cambodia","volume":"60","author":"Leang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0150","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"Roper","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pt.2020.09.011_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","article-title":"The public health impact of chloroquine resistance in Africa","volume":"64","author":"Trape","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.09.011_bb0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature00813","article-title":"Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum","volume":"418","author":"Wootton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.09.011_bb0165","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/ciy1038","article-title":"Novel pfkelch13 gene polymorphism associates with artemisinin resistance in Eastern India","volume":"69","author":"Das","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0170","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of artemisinin-resistant Plasmodium falciparum malaria in Eastern India","volume":"379","author":"Das","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0175","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","article-title":"Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania","volume":"10","author":"Bwire","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2020.09.011_bb0180","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"Menard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0185","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51015","article-title":"Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance","volume":"9","author":"Mathieu","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.pt.2020.09.011_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","article-title":"Drugs in development for malaria","volume":"78","author":"Ashley","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.pt.2020.09.011_bb0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0210","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/14656566.2016.1187134","article-title":"Can new treatment developments combat resistance in malaria?","volume":"17","author":"White","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.pt.2020.09.011_bb0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12936-018-2182-z","article-title":"Poor response to artesunate treatment in two patients with severe malaria on the Thai\u2013Myanmar border","volume":"17","author":"Phyo","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0220","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.09.011_bb0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001984","article-title":"The community as the patient in malaria-endemic areas: preempting drug resistance with multiple first-line therapies","volume":"13","author":"Boni","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.09.011_bb0240","first-page":"301","article-title":"Delaying antimalarial drug resistance with combination chemotherapy","volume":"41","author":"White","year":"1999","journal-title":"Parassitologia"},{"key":"10.1016\/j.pt.2020.09.011_bb0245","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.pt.2020.09.011_bb0250","series-title":"WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.pt.2020.09.011_bb0255","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.09.011_bb0260","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/AAC.05163-14","article-title":"Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquine","volume":"59","author":"Lim","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.09.011_bb0270","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.09.011_bb0275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","article-title":"In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria","volume":"120","author":"Folarin","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2020.09.011_bb0280","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.09.011_bb0285","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"Sisowath","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0290","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1475-2875-11-270","article-title":"Review of pyronaridine anti-malarial properties and product characteristics","volume":"11","author":"Croft","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0295","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/jac\/dks504","article-title":"Antimalarial pharmacology and therapeutics of atovaquone","volume":"68","author":"Nixon","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.00679-09","article-title":"Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda","volume":"54","author":"Mwesigwa","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0305","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2011.254","article-title":"Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria","volume":"91","author":"Tarning","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2020.09.011_bb0310","article-title":"The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data","volume":"10","author":"WorldWide Antimalarial Resistance Network, D.P.S.G","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0315","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pt.2007.11.008","article-title":"Antimalarial dosing regimens and drug resistance","volume":"24","author":"Barnes","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.09.011_bb0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1475-2875-8-253","article-title":"Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance","volume":"8","author":"White","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0325","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.clpt.2006.08.016","article-title":"Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications","volume":"80","author":"Barnes","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2020.09.011_bb0330","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00060-19","article-title":"Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults","volume":"63","author":"Hanboonkunupakarn","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0335","series-title":"The Cardiotoxicity of Antimalarials","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.pt.2020.09.011_bb0340","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","article-title":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review","volume":"16","author":"Haeusler","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0345","first-page":"505","article-title":"The evolution of drug-resistant malaria: the role of drug elimination half-life","volume":"357","author":"Hastings","year":"2002","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.pt.2020.09.011_bb0350","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12936-015-1075-7","article-title":"Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa","volume":"15","author":"Slater","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0355","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pt.2016.09.004","article-title":"Mathematical modelling to guide drug development for malaria elimination","volume":"33","author":"Slater","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.09.011_bb0360","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/1475-2875-13-452","article-title":"Artemisinin resistance--modelling the potential human and economic costs","volume":"13","author":"Lubell","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0365","doi-asserted-by":"crossref","first-page":"e01068-18","DOI":"10.1128\/AAC.01068-18","article-title":"Investigating the efficacy of triple artemisinin-based combination therapies for treating Plasmodium falciparum malaria patients using mathematical modeling","volume":"62","author":"Dini","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2020.09.011_bb0370","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12936-015-1042-3","article-title":"Ethical aspects of malaria control and research","volume":"14","author":"Jamrozik","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0375","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/inthealth\/ihw027","article-title":"Antimalarial mass drug administration: ethical considerations","volume":"8","author":"Cheah","year":"2016","journal-title":"Int. Health"},{"key":"10.1016\/j.pt.2020.09.011_bb0380","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1472-698X-9-26","article-title":"Barriers to the effective treatment and prevention of malaria in Africa: A systematic review of qualitative studies","volume":"9","author":"Maslove","year":"2009","journal-title":"BMC Int. Health Hum. Rights"},{"key":"10.1016\/j.pt.2020.09.011_bb0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.2007.77.193","article-title":"A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies","volume":"77","author":"Bosman","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.09.011_bb0390","series-title":"Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance","first-page":"312","article-title":"Maximizing the effective use of antimalarial drugs","year":"2004"},{"key":"10.1016\/j.pt.2020.09.011_bb0395","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/heapol\/czh051","article-title":"The process of changing national malaria treatment policy: lessons from country-level studies","volume":"19","author":"Williams","year":"2004","journal-title":"Health Policy Plan."},{"key":"10.1016\/j.pt.2020.09.011_bb0400","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1590\/1413-81232017227.04042017","article-title":"Challenges in a product development partnership: a malaria treatment case study","volume":"22","author":"Luiza","year":"2017","journal-title":"Cien Saude Colet"},{"key":"10.1016\/j.pt.2020.09.011_bb0405","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","article-title":"Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data","volume":"14","author":"WWARN Gametocyte Study Group","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.pt.2020.09.011_bb0410","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.actatropica.2005.04.014","article-title":"Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum","volume":"94","author":"Barnes","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2020.09.011_bb0415","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12936-019-2976-7","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against","volume":"18","author":"Krishna","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0420","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12936-019-2955-z","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance","volume":"18","author":"White","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.09.011_bb0425","series-title":"Global Technical Strategy for Malaria","first-page":"2016","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.pt.2020.09.011_bb0430","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0140-6736(18)30911-5","article-title":"The Lancet Commission on malaria eradication","volume":"391","author":"Chen","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.09.011_bb0440","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.trstmh.2008.11.002","article-title":"The evolution of drug-resistant malaria","volume":"103","author":"Plowe","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2020.09.011_bb0445","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2020.09.011_bb0450","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2020.09.011_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30228-0","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study","author":"Imwong","year":"2020","journal-title":"Lancet Infect. Dis."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220302543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220302543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:36:39Z","timestamp":1761464199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492220302543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1471492220302543"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2020.09.011","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple Artemisinin-Based Combination Therapies for Malaria \u2013 A New Paradigm?","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}